Great West Life Assurance CO Global Blood Therapeutics, Inc. Transaction History

Great West Life Assurance CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$22.3 - $37.39 $14,695 - $24,640	659 Added 24.62%	3,336 $107,000
Q1 2022 May 12, 2022	SELL	$25.68 - $35.59 $15,253 - $21,140	-594 Reduced 18.16%	2,677 $99,000
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $31,775 - $41,493	-816 Reduced 19.97%	3,271 $132,000
Q3 2020 Nov 17, 2020	BUY	$52.76 - $74.49 $215,630 - $304,440	4,087 New	4,087 $225,000
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $215,630 - $304,440	-4,087 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$45.7 - $81.86 $186,775 - $334,561	4,087 New	4,087 $324,000
Q3 2019 Oct 25, 2019	SELL	$45.35 - $57.91 $337,902 - $431,487	-7,451 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$52.6 - $63.29 $36,188 - $43,543	688 Added 10.17%	7,451 $0
Q4 2018 Feb 12, 2019	BUY	$31.54 - $46.67 $56,582 - $83,725	1,794 Added 36.1%	6,763 $268,000
Q2 2018 Aug 10, 2018	BUY	$38.7 - $50.15 $56,850 - $73,670	1,469 Added 41.97%	4,969 $224,000
Q3 2017 Nov 09, 2017	BUY	$25.1 - $31.05 $87,850 - $108,675	3,500	3,500 $103,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.